• Protocols

• S2303

  OPEN TO ACCRUAL

  Adding Nivolumab to Usual Treatment for People with Advanced Stomach or Esophageal Cancer
  
  

• UW24004

  OPEN TO ACCRUAL

  P3 Study: Dato-DXd With or Without Durvalumab VS. Choice Chemo + Pembro in Pt w/PD-L1+ or Met TNBC